Chemoinformaics analysis of Methyl pyruvate
| Molecular Weight | 102.089 | nRot | 1 |
| Heavy Atom Molecular Weight | 96.041 | nRig | 2 |
| Exact Molecular Weight | 102.032 | nRing | 0 |
| Solubility: LogS | 0.389 | nHRing | 0 |
| Solubility: LogP | -0.084 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 13 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 7 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 4 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 13.0868 |
| nHD | 0 | BPOL | 9.49124 |
| QED | 0.338 |
| Synth | 2.269 |
| Natural Product Likeliness | 0.589 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.384 |
| MDCK | 0.0000876 |
| BBB | 0.985 |
| PPB | 0.245237 |
| VDSS | 0.388 |
| FU | 0.707083 |
| CYP1A2-inh | 0.538 |
| CYP1A2-sub | 0.832 |
| CYP2c19-inh | 0.186 |
| CYP2c19-sub | 0.665 |
| CYP2c9-inh | 0.016 |
| CYP2c9-sub | 0.315 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.367 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.291 |
| CL | 6.725 |
| T12 | 0.834 |
| hERG | 0.009 |
| Ames | 0.325 |
| ROA | 0.033 |
| SkinSen | 0.843 |
| Carcinogencity | 0.027 |
| EI | 0.989 |
| Respiratory | 0.287 |
| NR-Aromatase | 0.016 |
| Antiviral | No |
| Prediction | 0.979309 |